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Timing of Acute Respiratory Distress
Syndrome Onset is Related to 
Patient Outcome
Kuang-Ming Liao,1,4 Chang-Wen Chen,2 Tzuen-Ren Hsiue,3 Wei-Chieh Lin2,4*
Background/Purpose: Acute respiratory distress syndrome (ARDS) is a major cause of mortality and mor-
bidity in adult intensive care units. The relationship between the timing of ARDS onset and outcome is
not well known. The objective of this study was to investigate the outcome of patients with late-onset
ARDS during hospitalization.
Methods: We prospectively enrolled patients who were intubated and fulfilled ARDS criteria in medical
and surgical intensive care units in a tertiary referral medical center from December 1, 2004 to May 31,
2006. Those who developed ARDS more than 48 hours after hospital admission were categorized as late-
onset ARDS; otherwise, they were defined as early-onset ARDS. We assessed the risk factors for hospital
mortality using multivariate analysis and 90-day survival using Kaplan–Meier analysis between early- and
late-onset ARDS, and between direct and indirect ARDS.
Results: A total of 172 patients were included in the study. Overall mortality rate was 70%. Late-onset
ARDS [odds ratio (OR): 3.06; 95% confidence interval (CI): 1.41 to 6.63; p = 0.005] and initial shock (OR:
8.20; 95% CI: 3.39–19.79; p < 0.001) were the independent risk factors for hospital mortality. Patients
with late-onset ARDS had higher hospital mortality rate (83% vs. 60%; p = 0.002), longer duration of me-
chanical ventilation (27.0 ± 23.4 vs.14.6 ± 11.5 days; p < 0.001) and length of intensive care unit stay
(25.5 ± 20.6 vs. 15.6 ± 13.6 days; p < 0.001) than patients with early-onset ARDS. The 90-day survival
showed that both early-onset ARDS and direct ARDS were associated with better survival.
Conclusion: Patients with late-onset ARDS are associated with poor prognosis and should be managed as
high-risk patients. [J Formos Med Assoc 2009;108(9):694–703]
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Acute respiratory distress syndrome (ARDS), ini-
tially described by Ashbaugh and colleagues in
1967,1 is characterized by acute respiratory failure
secondary to comprehensive lung inflammation
and high-permeability lung edema. It is the most
severe of the lung pathogenic processes that are
designated as acute lung injury2 and a major cause
of mortality and morbidity in adults admitted to
the intensive care unit (ICU). Previously reported
mortality rates in individual series vary from 30%
to 70%, even with optimal conventional ther-
apy.3,4 Although more recent studies have shown
some decrease in mortality5,6 since lung protective
ventilation strategies have been introduced to
manage patients,7 the mortality remains high.
Pneumonia and sepsis are the most common
triggering factors of direct and indirect ARDS, re-
spectively. Some studies have reported that lung
injury that results from direct and indirect insults
may contribute to different outcomes.8–10 Also, a
number of clinical risk factors associated with poor
outcome have been identified, including advanced
age, chronic liver disease, and nonpulmonary or-
gan dysfunction,4,6,11–13 but the contribution of
these factors is diverse in individual studies.
With regard to the impact of the timing of ARDS
onset on patient outcome, Croce and colleagues14
demonstrated that early and late posttraumatic
ARDS are two distinct forms of ARDS, but no asso-
ciation was found between the timing of ARDS
onset and outcome. However, its prognostic value
in the general ICU population has not been fully
elucidated. In the present study, we investigated
whether the timing of ARDS onset, which is asso-
ciated with the severity of initial illness and the
effectiveness of initial therapy, can be an inde-
pendent prognostic factor in the general ICU set-
ting, and other factors related to patient outcome.
Patients and Methods
This was a prospective study conducted in the
medical and surgical ICU of National Cheng
Kung University Hospital, a tertiary referral center
in southern Taiwan, between December 2004 and
May 2006. All patients who were intubated with
mechanical ventilation for acute respiratory failure
were evaluated daily to identify those with ARDS.
They received arterial blood gas analysis and chest
radiography daily for at least 2 days. The frequency
was reduced if their condition improved; other-
wise, it was increased as needed. We also assessed
heart function if clinical features of heart failure
were suspected. Patients were enrolled if they
met the criteria for diagnosis of ARDS defined 
by the North American/European Consensus
Conference: arterial hypoxemia (PaO2/FiO2
< 200 mmHg), bilateral infiltrates on chest radi-
ographs, normal pulmonary artery occlusive
pressure (pulmonary artery wedge pressure
< 18 cmH2O), or no evidence of heart failure.2 To
rule out patients whose hypoxemia was caused
potentially by atelectasis, pulmonary hemorrhage,
or hydrostatic pulmonary edema caused by dis-
eases other than heart failure, we excluded those
whose hypoxemia (PaO2/FiO2 < 200 mmHg) and
bilateral infiltrates on chest radiographs were
improved within 24 hours. Only the first episode
of ARDS was included for those who developed
ARDS several times during the study period. All
cases were reviewed by two independent clini-
cians, and a third opinion was obtained if incon-
sistency existed. All patients received treatment
for ARDS using protocols that followed lung 
protective strategy7 and the Surviving Sepsis
Campaign guidelines.15
Baseline characteristics such as age, sex, comor-
bidity, days from admission to ARDS onset, labo-
ratory data including PaO2/FiO2 ratio, blood cell
count, serum biochemical data, and parameters of
lung mechanics such as static compliance, were re-
corded on the first day of ARDS onset for further
analysis. Hemodynamic data, ventilator parame-
ters and laboratory data were collected, and the
worst daily values for all variables of interest were
recorded to calculate the Sequential Organ Failure
Assessment (SOFA) scores,16 Acute Physiology and
Chronic Health Evaluation II (APACHE II) score,17
and Lung Injury Score (LIS) as defined by Murray
and colleagues18 within the first 24 hours of ARDS
onset. The study was approved by our Institutional
Review Board.
The etiology of ARDS, defined as the specific
clinical disorder associated with ARDS, was ascer-
tained on the basis of medical history, radiology,
biochemical and microbiological investigations.
Direct and indirect ARDS were defined according
to the published consensus guidelines for the 
diagnosis of ARDS.2 Initial shock was defined 
as systolic blood pressure < 90 mmHg or the use
of vasopressors, defined as follows: > 5 μg/kg/
minute dopamine or any dose of norepineph-
rine, epinephrine, or vasopressin on the first day
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of ARDS onset. Chronic diseases (liver, cardio-
vascular, respiratory or renal) were defined ac-
cording to APACHE II score.17 Immunodeficiency
was categorized and noted as immunosuppres-
sive therapy and human immunodeficiency virus
infection with CD4 + cell count < 200/mm3. To
investigate the impact of the timing of ARDS
onset on clinical outcome, we defined early-onset
ARDS as that occurring within 48 hours from
hospital admission (to reflect the severity of ini-
tial illness on admission), and late-onset ARDS
as that developing more than 48 hours after hos-
pital admission. During the first 48 hours after
hospital admission, evolution of disease and re-
sponse to treatment provided valuable prognostic
information. We also followed patients who were
discharged from our hospital for 1 year to investi-
gate the ultimate outcome, either by medical chart
or telephone visit.
Statistical analyses
Statistical analyses were performed using SPSS
version 13.0 (SPSS Inc., Chicago, IL, USA) for
Windows. Descriptive frequencies were expressed
using mean ± standard deviation. Differences be-
tween the means of continuous variables were
compared using the Mann–Whitney U test, and
those of categorical variables were compared
with the χ2 test. Levels of significance were ex-
pressed as p values and odds ratios (ORs) [95%
confidence intervals (CIs)]. Stepwise multivari-
ate logistic regression analysis was performed to
analyze the independent risk factors for hospital
mortality. Initially, the variables (i.e. age, sex, un-
derlying condition, etiology, laboratory data,
static compliance, SOFA score, APACHE II score,
and LIS score) were analyzed using univariate
analysis. The variables that were found to be sig-
nificant or nearly significant (i.e. p < 0.10) on
univariate analysis were then entered into a mul-
tivariate logistic regression model to derive the
adjusted ORs and CIs. Survival curves were con-
structed to study the effect of different categories
of ARDS on 90-day survival using Kaplan–Meier
analysis. The difference between two survival
curves was analyzed using the log-rank test.
Results
During the study period, a total of 4861 patients
were admitted to our ICU. There were 260 me-
chanically ventilated patients who had at least
one episode of PaO2/FiO2 ratio < 200 during their
ICU stay, but only 172 patients fulfilled our ARDS
criteria and were included for further analysis.
There were 110 men and 62 women included in
the study. Fifty-one (30%) of our patients survived,
with a mean age of 65.9 ± 16.3 years, and 121 pa-
tients died in hospital, with a mean age of 63.0 ±
18.7 years. Overall mortality rate for the entire
population was 70%. Late-onset ARDS was more
common among the patients who died in hospi-
tal (p = 0.002; Table 1). This group of patients also
had a higher SOFA score (11.6 ± 4.0 vs. 9.9 ± 3.1;
p = 0.012), a greater proportion with initial shock
(92% vs. 57%; p < 0.001), and lower platelet
count (168.3 ± 127.1 vs. 226.3 ± 132.4 103/mm3;
p = 0.005) on the day of ARDS onset (Table 1).
They also had shorter duration of mechanical
ventilation (18.2 ± 16.7 vs. 25.4 ± 23.0 days;
p = 0.013) and length of ICU stay (18.7 ± 16.9 vs.
23.8 ± 19.7 days; p = 0.022) because most of
them died early during hospitalization (Table 1).
However, no significant difference was found in
sex, underlying medical condition, etiology of
ARDS, LIS and APACHE II scores on the diagno-
sis of ARDS as compared with patients who sur-
vived (Table 1). The multivariate analysis model
demonstrated that late-onset ARDS (OR: 3.06;
95% CI: 1.41–6.63; p = 0.005) and initial shock
(OR: 8.20; 95% CI: 3.39–19.79; p < 0.001) were
the independent risk factors for hospital mortal-
ity (Table 2).
When we further analyzed patients with late-
onset ARDS, they more often had underlying
liver diseases (18% vs. 5%; p = 0.023) and ARDS
caused by sepsis (31% vs. 15%; p = 0.020) than
patients with early-onset ARDS (Table 3). They
were also associated significantly with higher
PaO2/FiO2 ratio at the time of ARDS onset (130.8±
40.1 vs. 112.2 ± 44.7; p = 0.007; Table 3). Except for
higher hospital mortality (83% vs. 60%; p=0.002),
they had longer duration of mechanical ventilation
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Table 1. Comparison of the characteristics between patients who survived and those who died during
hospitalization*
Alive (n = 51) Dead (n = 121) p
Age (yr) 65.9 ± 16.3 63.0 ± 18.7 0.388
Sex, male 38 (75) 72 (60) 0.089
Direct injury 37 (73) 73 (60) 0.177
Medical patients 39 (76) 81 (67) 0.289
Late-onset ARDS 14 (27) 66 (55) 0.002
Days from admission to ARDS onset 4.6 ± 6.4 11.1 ± 14.1 0.006
Underlying condition
DM 14 (27) 29 (24) 0.772
Chronic liver disease 3 (6) 16 (13) 0.256
Chronic cardiovascular disease 8 (16) 8 (7) 0.083
Chronic respiratory disease 4 (8) 21 (17) 0.168
Chronic kidney disease 11 (22) 15 (12) 0.193
Malignancy 10 (20) 33 (27) 0.386
Connective tissue disease 2 (4) 8 (7) 0.725
Immunodeficiency 5 (10) 6 (5) 0.398
Etiology of ARDS
Pneumonia 36 (71) 71 (59) 0.194
Sepsis 11 (22) 28 (23) 0.980
Severe trauma 1 (2) 9 (7) 0.285
ICH 0 2 (2) 1.000
Major operation 0 4 (3) 0.320
Burn 0 2 (2) 1.000
Acute pancreatitis 1 (2) 1 (1) 0.506
Drug overdose 2 (4) 0 0.087
Corrosive injury 0 4 (3) 0.320
Complications
Hemodialysis 11 (22) 26 (21) 1.000
Initial shock 29 (57) 111 (92) < 0.001
DIC 12 (24) 49 (40) 0.051
Duration of mechanical ventilation (d) 25.4 ± 23.0 18.2 ± 16.7 0.013
Duration of ICU stay (d) 23.8 ± 19.7 18.7 ± 16.9 0.022
Bacteremia 21 (41) 51 (42) 1.000
APACHE II score 26.6 ± 7.2 29.3 ± 7.5 0.054
SOFA score 9.9 ± 3.1 11.6 ± 4.0 0.012
LIS 3.4 ± 0.6 3.5 ± 0.4 0.343
PaO2/FiO2 119.7 ± 41.0 121.3 ± 44.6 0.820
WBC (103/mm3) 15.3 ± 8.7 14.3 ± 9.8 0.405
Platelet count (103/mm3) 226.3 ± 132.4 168.3 ± 127.1 0.005
BUN (mg/dL) 38.5 ± 28.2 48.2 ± 40.6 0.404
Serum creatinine (mg/dL) 2.4 ± 2.8 2.2 ± 2.4 0.671
Static compliance 28.0 ± 13.9 23.7 ± 9.6 0.119
*Data presented as mean ± standard deviation or n (%). ARDS = acute respiratory distress syndrome; DM = diabetes mellitus; ICH =
intracranial hemorrhage; DIC = disseminated intravascular coagulation; ICU = intensive care unit; APACHE = Acute Physiology and
Chronic Health Evaluation; SOFA = Sequential Organ Failure Assessment; LIS = Lung Injury Score; WBC = white blood cell count;
BUN = blood urea nitrogen.
(27.0 ± 23.4 vs.14.6 ± 11.5 days; p < 0.001) and
length of ICU stay (25.5 ± 20.6 vs. 15.6 ± 13.6
days; p < 0.001) than patients with early-onset
ARDS (Table 3). In Kaplan–Meier estimates of
90-day survival, early-onset ARDS was associated
with decreased mortality [hazard ratio (HR):
0.63; 95% CI: 0.43–0.87; p = 0.007; Figure 1A].
Likewise, there was a trend towards decreased
mortality after hospital discharge within 1 year
follow-up in early-onset ARDS patients, although
no significant difference was noted between the
two groups (Figure 1B).
Pneumonia and sepsis were the leading cause
of direct and indirect ARDS respectively (Table 4).
Patients with direct ARDS were associated with
lower PaO2/FiO2 ratio (116.1±41.4 vs. 129.2±46.1;
p=0.047) and SOFA score (10.2±3.5 vs. 12.8±3.9;
p < 0.001), which was consistent with less multi-
ple organ involvement, as indicated by higher
platelet count (211.5 ± 133.9 vs. 139.4 ± 112.7
103cells/mm3; p < 0.001), lower bilirubin level
(2.2 ± 3.7 vs. 6.5 ± 8.1 mg/dl; p < 0.001), and fewer
patients requiring hemodialysis (16% vs. 31%;
p = 0.046; Table 4), at the onset of ARDS (Table 4).
Patients with direct ARDS showed increased 90-day
survival (HR: 0.53; 95% CI: 0.31–0.71; p = 0.0003)
as compared with those with indirect ARDS
(Figure 2), although no significant difference in
hospital mortality was noted (Table 4). However,
a longer duration of mechanical ventilation was
required in patients with direct ARDS (21.9 ± 17.9
vs. 17.7 ± 20.7 days; p = 0.021; Table 4).
Discussion
The timing of ARDS onset during hospitalization
is associated with the severity of initial illness
upon admission, underlying comorbidity and re-
sponse to initial therapy, as well as other factors
including adequacy of initial treatment, occurrence
of complications, and the length of mechanical
ventilation prior to ARDS.4 However, we propose
that the timing of ARDS onset during hospital-
ization may be an independent factor for pre-
dicting the outcome of patients with ARDS.
We demonstrated that late-onset ARDS con-
tributed to increased mortality, and longer dura-
tion of mechanical ventilation and length of ICU
stay. Similar prognostic factors for ARDS have
also been identified previously.19 In the study of
Monchi and colleagues,4 the length of mechani-
cal ventilation before the onset of ARDS was an
independent risk factor for mortality. The previous
length of hospital stay before acute lung injury
criteria has also been shown to be associated with
mortality.20 In contrast, Croce and colleagues have
shown no difference between early and late-onset
ARDS mortality rates.14 These differences can be
explained by the different study populations, e.g.
younger patients (mean age, 40 years) with post-
traumatic ARDS in the previous study compared
with the older general ARDS population (mean
age, 64 years) in our study, as well as the available
facilities in each center. Furthermore, we demon-
strated by multivariate analysis that only late-
onset ARDS and initial shock were independent
risk factors for hospital mortality.
When patients with and without late-onset
ARDS were analyzed further, we found that late-
onset ARDS was associated with increased under-
lying liver disease and sepsis. This is in line with
the results of previous studies,4,11,12,21 which have
suggested that chronic liver disease and sepsis
are related to risk factors for ARDS mortality, and
they may contribute to increased mortality in pa-
tients with late-onset ARDS. In addition, patients
with late-onset ARDS were shown to have longer
duration of mechanical ventilation and length of
ICU stay. This implies that another study investi-
gating the cost of medical resources for this sub-
set of patients is necessary. We also found a trend
towards decreased survival in patients with late-
onset ARDS within 1 year after hospital discharge.
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Table 2. Independent prognostic factors of
hospital mortality
Factors p
Odds 95% confidence 
ratio interval
Late onset 0.005 3.06 1.41–6.63
Initial shock 0.000 8.20 3.39–19.79
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Table 3. Comparison of the characteristics between the early- and late-onset ARDS groups*
Variables
Early-onset ARDS Late-onset ARDS 
p
(n = 92) (n = 80)
Age (yr) 62.8 ± 18.0 65.2 ± 18.0 0.277
Sex, male 62 (67) 48 (60) 0.397
Direct injury 63 (68) 47 (59) 0.244
Medical patients 66 (72) 54 (68) 0.662
Days from admission to ARDS onset 0.5 ± 0.7 15.8 ± 13.4 < 0.001
Underlying condition
DM 20 (22) 23 (29) 0.377
Chronic liver disease 5 (5) 14 (18) 0.023
Chronic cardiovascular disease 9 (10) 7 (9) 1.000
Chronic respiratory disease 12 (13) 13 (16) 0.705
Chronic kidney disease 11 (12) 14 (18) 0.417
Malignancy 17 (18) 24 (30) 0.112
Connective tissue disease 4 (4) 6 (8) 0.579
Immunodeficiency 6 (7) 5 (6) 1.000
Etiology of ARDS
Pneumonia 61 (66) 46 (58) 0.303
Sepsis 14 (15) 25 (31) 0.020
Severe trauma 8 (9) 2 (3) 0.108
ICH 0 2 (3) 0.215
Major operation 1 (1) 3 (4) 0.339
Burn 2 (2) 0 0.500
Acute pancreatitis 2 (2) 0 0.500
Drug overdose 2 (2) 0 0.500
Corrosive injury 2 (2) 2 (3) 1.000
Complications
Hemodialysis 15 (16) 22 (28) 0.110
Initial shock 71 (77) 69 (86) 0.184
DIC 26 (28) 35 (44) 0.050
Duration of mechanical ventilation (d) 14.6 ± 11.5 27.0 ± 23.4 < 0.001
Duration of ICU stay (d) 15.6 ± 13.6 25.5 ± 20.6 < 0.001
Bacteremia 36 (39) 36 (45) 0.533
Hospital mortality 55 (60) 66 (83) 0.002
APACHE II score 27.9 ± 7.3 29.3 ± 7.6 0.355
SOFA score 10.5 ± 3.5 11.8 ± 4.1 0.056
LIS 3.5 ± 0.5 3.4 ± 0.5 0.156
PaO2/FiO2 112.2 ± 44.7 130.8 ± 40.1 0.007
WBC (103/mm3) 14.0 ± 8.4 15.3 ± 10.6 0.472
Platelet count (103/mm3) 202.7 ± 135.0 165.8 ± 124.2 0.075
BUN (mg/dL) 36.5 ± 30.7 55.4 ± 42.0 0.002
Serum creatinine (mg/dL) 1.9 ± 2.2 2.7 ± 2.7 0.120
Static compliance 25.4 ± 10.9 24.6 ± 11.5 0.570
*Data presented as mean ± standard deviation or n (%). ARDS = acute respiratory distress syndrome; DM = diabetes mellitus; ICH =
intracranial hemorrhage; DIC = disseminated intravascular coagulation; ICU = intensive care unit; APACHE = Acute Physiology and
Chronic Health Evaluation; SOFA = Sequential Organ Failure Assessment; LIS = Lung Injury Score; WBC = white blood cell count;
BUN = blood urea nitrogen.
This indicates that the impact of late-onset ARDS
on outcome may last for 1 year after discharge.
The commonly associated clinical disorders
that induce ARDS include diseases that cause di-
rect or indirect lung injury.22,23 In the present
study, pneumonia and sepsis were the major
cause of direct and indirect ARDS, respectively.
The reported mortality rate in patients with ARDS
attributable to direct and indirect causes varies
considerably. In the present study, although there
was no significant difference in hospital mortal-
ity between direct and indirect ARDS, it displayed
that patients with direct ARDS had increased 
90-day survival. In contrast, some studies4,8 have
suggested decreased survival with direct ARDS,
and other studies23,24 have shown no relation-
ship between direct pulmonary insult and in-
creased mortality. The lack of agreement among
these studies can be explained by differences in
baseline conditions, study population, differen-
tiation between direct and indirect insult, and
the impact of therapy. Greater multiple organ in-
volvement in our patients with indirect ARDS
may be the reason for lower 90-day survival, al-
though they were younger than the direct ARDS
group.
The relatively high mortality rate (approxi-
mately 70%) in our patients with ARDS is similar
to one previous study,4 but lower than another,25
although a slowly declining annual ARDS mortal-
ity has been reported in recent years.26,27 The main
reason may be the selection bias as more severe
and older ARDS patients, based on APACHE II,
SOFA and LIS scores, were admitted to our ICU.
Meanwhile, we excluded patients with tempo-
rary hypoxemia or bilateral infiltrates on chest
radiographs lasting < 24 hours, to eliminate the
possible causes other than ARDS, such as atelec-
tasis, pulmonary hemorrhage or fluid overload.
However, we may have excluded some patients
with relatively mild ARDS who could have im-
proved rapidly by adequate ventilator setting.
Other possible reasons are the obvious differ-
ences in case mix, and delays in the admission of
critically ill patients into the ICU because of the
limited availability of beds.
The main strength of this study is that, to the
best of our knowledge, we were the first to inves-
tigate prospectively the relationship between the
timing of ARDS onset after admission and pa-
tient outcome, with continued follow-up for 1
year after hospital discharge in the non-selected
ARDS population. We suggest that, in future
therapeutic studies of ARDS, treatment outcome
should be analyzed separately in each group. The
major limitations of our study include its small
sample size in a single medical center, and the
lack of generalizability of the results because of
our restricted enrolment criteria.
In conclusion, late-onset ARDS and initial
shock are independent risk factors for mortality
in patients with ARDS. Patients with late-onset
K.M. Liao, et al
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Figure 1. Comparison between patients with early-onset acute respiratory distress syndrome (ARDS) and those with
late-onset ARDS. (A) 90-day survival after onset of ARDS, hazard ratio (HR) = 0.63 [95% confidence interval (CI):
0.43–0.87]; p = 0.007. (B) Within 1 year after hospital discharge, HR = 0.58 (95% CI: 0.13–2.07); p = 0.359.
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Table 4. Comparison of the characteristics between patients with direct and indirect ARDS*
Variables Direct (n = 110) Indirect (n = 62) p
Age (yr) 66.1 ± 17.3 59.9 ± 18.7 0.021
Sex, male 72 (65) 38 (61) 0.703
Medical patients 89 (81) 31 (50) < 0.001
Late-onset ARDS 47 (43) 33 (53) 0.244
Days from admission to ARDS onset 7.4 ± 10.4 12.5 ± 15.5 0.056
Underlying condition
DM 31 (28) 12 (19) 0.271
Chronic liver disease 10 (9) 9 (15) 0.403
Chronic cardiovascular disease 13 (12) 3 (5) 0.215
Chronic respiratory disease 19 (17) 6 (10) 0.258
Chronic kidney disease 17 (15) 9 (15) 1.000
Malignancy 28 (25) 15 (24) 1.000
Connective tissue disease 6 (5) 4 (6) 0.748
Immunodeficiency 9 (8) 2 (3) 0.331
Etiology of ARDS
Pneumonia 107 (97) 0
Sepsis 0 39 (63)
Severe trauma 2 (2) 8 (13)
ICH 0 2 (3)
Major operation 0 4 (6)
Burn 0 2 (3)
Acute pancreatitis 0 2 (3)
Drug overdose 0 2 (3)
Corrosive injury 1 (1) 3 (5)
Complications
Hemodialysis 18 (16) 19 (31) 0.046
Initial shock 85 (77) 55 (89) 0.100
DIC 34 (31) 27 (44) 0.134
Hospital mortality 73 (66) 48 (77) 0.177
Duration of mechanical ventilation (d) 21.9 ± 17.9 17.7 ± 20.7 0.021
Duration of ICU stay (d) 21.3 ± 16.8 18.3 ± 19.6 0.063
Bacteremia 47 (43) 25 (40) 0.884
APACHE II score 28.6 ± 7.6 28.4 ± 7.3 0.966
SOFA score 10.2 ± 3.5 12.8 ± 3.9 < 0.001
LIS 3.4 ± 0.5 3.5 ± 0.4 0.375
PaO2/FiO2 116.1 ± 41.4 129.2 ± 46.1 0.047
WBC (103/mm3) 14.7 ± 10.3 14.4 ± 8.0 0.727
Platelet count (103/mm3) 211.5 ± 133.9 139.4 ± 112.7 < 0.001
Serum bilirubin (mg/dL) 2.2 ± 3.7 6.5 ± 8.1 < 0.001
BUN (mg/dL) 41.6 ± 32.7 51.9 ± 44.4 0.613
Serum creatinine (mg/dL) 2.0 ± 2.2 2.8 ± 2.8 0.078
Static compliance 24.9 ± 11.0 25.2 ± 11.5 0.959
*Data presented as mean ± standard deviation or n (%). ARDS = acute respiratory distress syndrome; DM = diabetes mellitus; ICH =
intracranial hemorrhage; DIC = disseminated intravascular coagulation; ICU = intensive care unit; APACHE = Acute Physiology and
Chronic Health Evaluation; SOFA = Sequential Organ Failure Assessment; LIS = Lung Injury Score; WBC = white blood cell count;
BUN = blood urea nitrogen.
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ARDS are associated with poor prognosis and
should be managed as high-risk patients. Specific
management protocols should be developed to
improve survival.
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